Skip to main content
PMC home page
Gut logoLink to Gut
. 1978 Apr;19(4):290–293. doi: 10.1136/gut.19.4.290

Abnormal vitamin D metabolism in cirrhosis.

R T Jung, M Davie, J O Hunter, T M Chalmers, D E Lawson
PMCID: PMC1411919  PMID: 206489

Abstract

Vitamin D metabolism was investigated in 10 patients with cirrhosis. Mean plasma 25 hydroxycholecalciferol (25 OHD) centration in alcoholic cirrhosis was lower than in controls but the difference was not significant. In three patients restudied after the summer, plasma 25 OHD had risen. In contrast to the finding in normal subjects, the half-life of intravenously administered 3H cholecalciferol was short in cirrhotics and showed no correlation with plasma 25 OHD. Furthermore, the appearance of 3H 25 OHD from 3H cholecalciferol was reduced compared to the control group four hours after injection. Increased rate of metabolism of cholecalciferol and deficient production of 25 ohd contribute to vitamin D deficiency in liver disease.

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATKINSON M., NORDIN B. E., SHERLOCK S. Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med. 1956 Jul;25(99):299–312. [PubMed] [Google Scholar]
  2. Avioli L. V., Lee S. W., McDonald J. E., Lund J., DeLuca H. F. Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. J Clin Invest. 1967 Jun;46(6):983–992. doi: 10.1172/JCI105605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  4. Chalmers T. M., Hunter J. O., Davie M. W., Szaz K. F., Pelc B., Kodicek E. 1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure. Lancet. 1973 Sep 29;2(7831):696–699. doi: 10.1016/s0140-6736(73)92536-1. [DOI] [PubMed] [Google Scholar]
  5. Edelstein S., Charman M., Lawson D. E., Kodicek E. Competitive protein-binding assay for 25-hydroxycholecalciferol. Clin Sci Mol Med. 1974 Feb;46(2):231–240. doi: 10.1042/cs0460231. [DOI] [PubMed] [Google Scholar]
  6. Haddad J. G., Jr, Walgate J. Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis. J Clin Invest. 1976 Nov;58(5):1217–1222. doi: 10.1172/JCI108575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hepner G. W., Roginsky M., Moo H. F. Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis. 1976 Jul;21(7):527–532. doi: 10.1007/BF01464758. [DOI] [PubMed] [Google Scholar]
  8. Hunt S. P., O'Riordan J. L., Windo J., Truswell A. S. Vitamin D status in different subgroups of British Asians. Br Med J. 1976 Dec 4;2(6048):1351–1354. doi: 10.1136/bmj.2.6048.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Long R. G., Skinner R. K., Wills M. R., Sherlock S. Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet. 1976 Sep 25;2(7987):650–652. doi: 10.1016/s0140-6736(76)92463-6. [DOI] [PubMed] [Google Scholar]
  10. Mawer E. B., Schaefer K., Lumb G. A., Stanbury S. W. The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition. Clin Sci. 1971 Jan;40(1):39–53. doi: 10.1042/cs0400039. [DOI] [PubMed] [Google Scholar]
  11. Olson E. B., Jr, Knutson J. C., Bhattacharyya M. H., DeLuca H. F. The effect of hepatectomy on the synthesis of 25-hydroxyvitamin D3. J Clin Invest. 1976 May;57(5):1213–1220. doi: 10.1172/JCI108389. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES